<DOC>
	<DOCNO>NCT01388166</DOCNO>
	<brief_summary>The objective observational study collect evaluate data medication adherence patient maintenance COPD therapy long-acting anticholinergic ( e.g . Spiriva® deliver HandiHaler® Respimat® ) use MMAS-8 questionnaire .</brief_summary>
	<brief_title>ADESPI : Adherence Spiriva® Patients With COPD ( Chronic Obstructive Pulmonary Disease ) , Measured Morisky-8 ( MMAS-8 ) Scale , Routine Medical Practice</brief_title>
	<detailed_description>Purpose :</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Inclusion criterion : Male female ambulatory outpatient see participate physician office routine care , Patients clinical diagnosis COPD already treat maintenance therapy longacting anticholinergic ( Tiotropium ( Spiriva® HandiHaler® Respimat® ) least 1 month within product label Patient fluent language questionnaire cognitive functional ability require fill questionnaire alone Exclusion criterion : Uncooperative patient judge physician Patients condition exclude per Country specific package insert Patients currently enrol clinical trial require change medication respiratory problem .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>